Building Confidence in COVID-19 Vaccines (03/01/21) ▸
Most people in the United States are planning to get vaccinated with COVID-19 vaccines. But some may want more information about COVID-19 vaccines, including the process for developing and authorizing these vaccines and information about their safety and effectiveness.
ACP Physicians Guide | Resources: Vaccination Planning (03/01/21) ▸
The following information is provided to help clinical teams in their efforts to plan for and provide Covid-19 vaccinations.
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 (02/26/21) ▸
Health care providers and vaccine recipients can be reassured about the safety of Pfizer BioNTech and Moderna COVID-19 vaccines. Counseling vaccine recipients to expect transient local and systemic reactions might ease concerns and encourage completion of the 2-dose vaccination series.
Pfizer’s Vaccine Offers Strong Protection After First Dose (02/26/21) ▸
The coronavirus vaccine made by Pfizer and BioNTech provides strong protection against Covid-19 within about 10 days of the first dose, according to documents published on Tuesday by the Food and Drug Administration before a meeting of its vaccine advisory group.
COVID-19 Vaccines and Severe Allergic Reactions (02/25/21) ▸
If you had a severe allergic reaction after getting the first dose of an mRNA COVID-19 vaccine, CDC recommends that you should not get the second dose.
Frequently Asked Questions about COVID-19 Vaccination (02/25/21) ▸
This page has answers to commonly asked questions about COVID-19 vaccination.
Decline in Receipt of Vaccines by Medicare Beneficiaries During the COVID-19 Pandemic — United States, 2020 (02/19/21) ▸
Vaccination providers should emphasize the importance of routine adult vaccination to their patients and ensure the safe provision of vaccines to protect older adults from vaccine-preventable diseases during the ongoing COVID-19 pandemic.
COVID-19 Vaccine Effectiveness Research (02/18/20) ▸
After FDA approves a vaccine or authorizes a vaccine for emergency use, it continues to be studied to determine how well it works under real-world conditions. CDC and other federal partners will be assessing COVID-19 vaccine effectiveness under real-world conditions.
Understanding Viral Vector COVID-19 Vaccines (02/17/21) ▸
Viral vector vaccines use a modified version of a different virus (the vector) to deliver important instructions to our cells. For COVID-19 viral vector vaccines, the vector (not the virus that causes COVID-19, but a different, harmless virus) will enter a cell in our body and then use the cell’s machinery to produce a harmless piece of the virus that causes COVID-19. This piece is known as a spike protein and it is only found on the surface of the virus that causes COVID-19.
Ensuring the Safety of COVID-19 Vaccines in the United States (02/15/21) ▸
The U.S. vaccine safety system ensures that all vaccines are as safe as possible. Safety is a top priority while federal partners work to make a coronavirus disease 2019 (COVID-19) vaccine(s) available.
Myths and Facts about COVID-19 Vaccines (02/03/21)▸
In the United States, there is not yet an authorized or approved vaccine to prevent coronavirus disease 2019 (COVID-19). With the possibility of a limited supply of one or more COVID-19 vaccines becoming available before the end of 2020, accurate vaccine information is critical.
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) (02/03/21)▸
The FDA developed a detailed factsheet with information for providers administering vaccinations.
Preparing for COVID-19 Vaccination: A Call to Action for Clinicians on Immunization Information Systems (02/02/21) ▸
Vaccines for coronavirus disease 2019 (COVID-19) are currently being administered under emergency use authorization through a tiered prioritization process determined by states with federal guidance. As a critical component of vaccination plans, immunization information systems (IISs) play a central role in coordinating distribution, administration, documentation, and monitoring of COVID-19 vaccination by confidentially collecting and consolidating vaccination data from multiple providers within a geographic area.
Experts Provide Update on ‘Essential’ COVID-19 Vaccine Trials in Children, Teens (01/27/21) ▸
Health officials expect to see progress on COVID-19 vaccine trials in adolescents over the next several months and are stressing the importance of vaccines in fighting the pandemic.
COVID-19 Vaccination Toolkits (01/22/21) ▸
Get audience-specific toolkits for healthcare teams and community administrators.
Different COVID-19 Vaccines (01/15/21) ▸
As COVID-19 vaccines are authorized and then recommended for use in the United States, it will be important to understand what is known about each vaccine. CDC will provide information on who is and is not recommended to receive each vaccine and what to expect after vaccination, as well as ingredients, safety, and effectiveness.
FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines (01/04/21) ▸
As the first round of vaccine recipients become eligible to receive their second dose, we want to remind the public about the importance of receiving COVID-19 vaccines according to how they’ve been authorized by the FDA in order to safely receive the level of protection observed in the large randomized trials supporting their effectiveness.
How CDC Is Making COVID-19 Vaccine Recommendations (12/30/20)▸
CDC is making coronavirus disease 2019 (COVID-19) vaccination recommendations for the United States based on input from the Advisory Committee on Immunization Practices (ACIP). ACIP is a federal advisory committee made of up of medical and public health experts who develop recommendations on the use of vaccines in the U.S. public. ACIP holds regular meetings, which are open to the public and provide opportunity for public comment.
10 Things Healthcare Professionals Need to Know about U.S. COVID-19 Vaccination Plans (12/29/20) ▸
Although CDC does not have a role in developing COVID-19 vaccines, CDC has been working closely with health departments and partners to develop vaccination plans for when a vaccine is available. With the possibility of one or more COVID-19 vaccines becoming available before the end of the year, CDC provides 10 things healthcare professionals need to know about where those plans currently stand.
AHA Releases Additional COVID-19 Vaccine Resources for Hospitals and Health Systems (12/29/20) ▸
To help advance the public’s confidence and trust in the safety of COVID-19 vaccines and their distribution, the AHA continues to develop and collate resources that hospitals and health systems can use as COVID-19 vaccines become available in their communities.
The Importance of COVID-19 Vaccination for Healthcare Personnel (12/28/20) ▸
Based on recommendations from the Advisory Committee on Immunization Practices (ACIP), an independent panel of medical and public health experts, CDC recommends healthcare personnel be among those offered the first doses of COVID-19 vaccines.
COVID-19 Vaccine Communications Toolkit (12/22/20) ▸
The COVID-19 Vaccine Communications Toolkit was developed as a guide through the steps involved in planning, designing and executing a vaccine communications plan and campaign.
Understanding mRNA COVID-19 Vaccines (12/18/20) ▸
Within the next month, messenger RNA vaccines—also called mRNA vaccines—are likely to be some of the first COVID-19 vaccines authorized for use in the United States.
Factors Associated with Positive SARS-CoV-2 Test Results in Outpatient Health Facilities and Emergency Departments Among Children and Adolescents Aged <18 Years — Mississippi, September–November 2020 (12/18/20) ▸
In this investigation, children and adolescents who received positive test results for SARS-CoV-2 were more likely than were similarly aged participants who had negative test results to have had reported close contact with a person with confirmed COVID-19 and less likely to have had reported consistent mask use by students and staff members inside the school facility. Among participants with close contact with a person with COVID-19, close contacts of case-patients were more likely to be family members and less likely to be school or child care classmates than were those of control participants.
AAFP | COVID-19 Vaccine FAQ (12/12/20) ▸
Thinking ahead to what your patients may ask for, the AAFP’s COVID-19 Vaccine FAQs provides information to help you answer their questions, from how mRNA vaccines work to side effects to availability.
The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020 (11/27/20) ▸
In addition to scientific data and implementation feasibility, four ethical principles will assist ACIP in formulating recommendations for the initial allocation of COVID-19 vaccine: 1) maximizing benefits and minimizing harms; 2) promoting justice; 3) mitigating health inequities; and 4) promoting transparency.
COVID-19 Vaccine Codes and PC-ACE Software Update (11/12/20)▸
In anticipation of the availability of a vaccine(s), for the novel coronavirus (SARS-CoV-2) in response to the coronavirus disease 2019 (COVID-19), the American Medical Association (AMA), working with the Centers for Medicare & Medicaid Services (CMS), created new codes for the vaccine and the administration of the vaccine. To prepare for the vaccine administration claims, the PC-ACE software is also updated and ready for providers to download.
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (11/12/20) ▸
We conducted a first-in-human phase 1 clinical trial in healthy adults to evaluate the safety and immunogenicity of mRNA-1273. Here we report interim results of the trial.